Optical Innovation

ActivControl™
Lenses

Dual-focus soft contact lenses FDA-cleared for slowing the progression of myopia in children aged 8-12.

FDA Cleared

Authorized for myopia indications.

62% Efficacy

Slows axial elongation significantly.

Easy Handling

Daily disposable convenience.

High Oxygen

Silicone hydrogel material.

Clinical Evidence

The ActivControl technology relies on a dual-focus optical design. Two treatment zones create myopic defocus in the peripheral retina, while two correction zones provide clear vision.

Study Duration3 Years

Sample Size144 Subjects

Axial Elongation-0.32mm vs Control